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ABSTRACT 
Introduction: Physicians’ perspectives are essential for rational use of medicine (RUM) activities. This study aimed at evaluation of 
physicians’ attitudes and experiences about therapeutical management process in terms of RUM in primary and secondary care. 
Methods: A survey was applied to 1062 family physicians (FP) and 562 specialist physicians (SP) in Turkey. The questionnaire 
consisted of items assessing physicians’ RUM approaches, stratified by their demographic and occupational characteristics.  
Results: A total of 55.4% of FPs and 32.1% of SPs declared that they prescribed to “>80% of their patients”. The attitude of “no 
prescribing without physical examination” was more in females, in seniors, and in those with longer professional experiences in SP 
group (p<0.05), where no difference was found among FPs. More markedly in FPs, women provided more information than men 
about their patients’ diseases and pharmacological/non-pharmacological treatments. Most commonly demanded drugs by patients 
were “analgesics/antirheumatics”, “cold-medications”, and “antibiotics”. 
Conclusion: Physicians’ statements showed that patients had an underestimated tendency to demand specific drug prescriptions and 
physicians met such demands more than expected. Moreover, female physicians are more likely to inform their patients about 
pharmacotherapy details in both groups. These findings may be considered as beneficial for RUM dissemination activities. 
Key words: physicians, rational drug use, primary health care, hospitals, prescribing 
 
Article Info 
Received 17 Jan 2017; Review Completed 09 Feb 2017; Accepted 09 Feb 2017, Available online 15 March 2017 
Cite this article as: 
Akici A, Kilboz MM, Tamirci M, Aydin V, Mollahaliloglu S, Ozgulcu S, Alkan A, Evaluation of the attitudes and experiences of the family 
physicians and specialists relating to provided treatments in terms of rational use of medicine, Journal of Drug Delivery and 
Therapeutics. 2017; 7(2):18-28. DOI: http://dx.doi.org/10.22270/jddt.v7i2.1383  
*Address for Correspondence  
Prof Ahmet AKICI, MD,  
Department of Medical Pharmacology, Marmara University, School of Medicine, Maltepe, Istanbul, Turkey  
Tel: +90 216 421 22 22, Fax: +90 216 414 47 31, e-mail: aakici@marmara.edu.tr 
 
 
INTRODUCTION 
Recently, rational use of medicine (RUM) gains a vital 
importance regarding sustainable delivery of high-
quality healthcare. In case of failure to comply with the 
principles of the RUM, healthcare systems could be 
faced with significant risk, especially in terms of drug-
related problems and drug wastage. The role of the 
physicians in dealing with such threats is undisputedly 
important. World Health Organization (WHO) defined 
RUM as “patients receive medications appropriate to 
their clinical needs, in doses that meet their own 
individual requirements, for an adequate period of time, 
and at the lowest cost to them and their community”.1 As 
implied by this description, abiding by basic principles 
of treatment process is fundamental to reaching success 
in a specific area like drug utilization. It is obvious that 
adoption of this approach requires a professional, 
physician-centered understanding.
1-3
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The issues emerging in case of failure to comply with 
the requirements of RUM is known as irrational use of 
medicine (IUM), which is listed among the important 
health problems strongly focused on by Turkey and 
many other countries. Review of the attitudes and 
experiences of the physicians who play a key role in 
managing treatment, and consequent implementation of 
the necessary precautions may contribute to solve these 
problems. In this context, physicians usually failed to 
show expected level of performance to carry out RUM, 
as indicated in the literature.
4-12
 In fact, their 
performances might be influenced by certain factors 
such as the place where healthcare is provided, their 
occupational and demographic features. Recently, 
infrastructure of the healthcare services began to 
undergo fundamental changes in Turkey, where, for 
instance, family health centers (FHC) has replaced 
health centers and governmental state hospitals (SH) has 
experienced several changes and transformations.
13,14
 
Continuous monitoring, evaluation, and comparison of 
the dynamic process of drug utilization increases the 
success of the dissemination of the RUM. Thus, WHO 
and other partners are striving to develop various 
criteria, approaches, and opinions that may contribute to 
research methodology allowing for spread of 
RUM.
15,1,16,17
  
This study aimed at the evaluation of the prescription-
related attitudes and experiences of the family 
physicians (FP) and specialist physicians (SP) in terms 
of RUM and at the comparison of these two physician 
groups based on their general and professional 
characteristics that might influence their approach to 
RUM.  
METHOD 
In this descriptive study, a survey in May 2010 was 
applied to randomly chosen FPs working in FHCs in 
Turkey`s 12 provinces and to SPs working in SHs in 
these provinces. Upon the application of this face-to-
face interview survey to 1624 physicians in total, the 
knowledge, attitude, and experiences of the FPs and SPs 
regarding RUM were analyzed.  
The FP survey was planned to cover all the FPs working 
in FHCs in these provinces. However, some physicians 
who were inaccessible during the survey period due to 
some reasons like day-off or temporary assignment to 
other provinces were excluded from the survey, and the 
questionnaire was administrated to a total of 1062 FPs 
(response rate: 97.2%). With the support of the 
Provincial Health Directorates of these provinces, the 
number of the SPs working in SH of these provinces 
were determined and then the survey was applied to a 
total of 562 SPs out of the selected sample (response 
rate: 74.8%). In the survey applied to SPs, the data were 
collected without any restrictions regarding the expertise 
of physicians.  
The survey included physicians’ descriptive 
characteristics, drug utilization habits, knowledge, 
attitude, and experiences of both physicians and their 
patients regarding RUM. Answers of the FPs and SPs 
were compared as each group within themselves based 
on their demographic and occupational characteristics. 
Because of the extensive coverage of the collected 
information, research data will be discussed in different 
articles. This article only focuses on research data about 
physicians’ experiences and attitudes regarding their 
approaches to the patients. 
In order to implement the survey in 12 provinces, 
officially a permission received from Turkish Ministry 
of Health (MoH). After a training for interviewers 
including information about the aim of the survey, 
application format, and other related procedures, data 
collection was begun. Demographic characteristics of 
age and working duration were presented in groups to 
make these data easy to understand. Accordingly, the 
age group of the physicians was named as “younger 
physicians” for those being ≤35 year-old, “middle-aged 
physicians” for those 36-45 year-old and “45+ 
physicians” for those >45 year-old. Physicians were 
divided into two groups based on length of professional 
experiences. Accordingly, physicians working for “≤10 
years” and “>10 years” were classified as “junior” and 
“senior”, respectively. SPs were categorized according 
to their duration of expertise.  
For analyzing the data, Microsoft-Office-Excel and 
SPSS-11.5 statistics pack software were used. Chi-
square test was used to analyze within-group 
relationships of the FP and SPs’ data. P<0.05 was 
accepted as the level of statistical significance. 
RESULTS  
A total of 1624 physicians were surveyed, among which 
1062 (65.4%) were FPs and the remaining 562 (34.6%) 
were SPs. In both FP and SP groups, men were in the 
majority (68.9% and 74.2%, respectively) and mean age 
of the participants were 39.1±6.4 and 41.3±8.5, 
respectively. About half of FPs (50.8%) and 39.1% of 
SPs reported the duration from their graduation till 
survey as “11-20 years”. It was also detected that 55.5% 
of the SP completed their residency in a university 
hospital. 
Based on the participants’ statements, an average of 52 
and 48 patients per day were found to apply to an FP and 
an SP, respectively. Most FPs wrote a prescription in 
more than 40% of their patients, of which 55.4% 
“prescribed in 81-100% of the patients” and 43.2% 
“prescribed in 41-80% of the patients”. SPs replied same 
question as “prescribing 41-80% (56.3%) of the 
patients” and “prescribing 81-100% (32.1%) of the 
patients”. “Prescribing 40% and less of the patients” 
answer were 1.4% and 11.6% in FPs and SPs, 
respectively. 
The percentage of physicians who declared that they 
examined 3/4 of patients applied them were 40.1% in 
FPs and 84.9% in SPs. Physicians stating to prescribe in 
more than three-fourths of patients upon physical 
examination (PE) were 70.0% in FPs and 64.0% in SPs.  
Based on their experiences, the average number of drug 
items declared to be written by FPs and SPs were 
3.27±0.6 and 3.07±0.8 per prescription, respectively. 
When the details of the number of drugs per prescription 
(NDPP) were examined, in both groups most commonly 
“three drug items” (64.4% and 53.2%, respectively) 
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were prescribed, followed by “four drug items” (30.7% 
and 25.9%, respectively) and “two drug items” (4.7% 
and 19.4%, respectively). There was no FP who declared 
to write one drug item per prescription, which was 
detected to be written by five (0.9%) physicians in SP 
group.  
Only few physicians, 1.5% in the FP group and 0.7% in 
the SP group, stated that “they wrote a prescription to 
their patients just based on their complaints without 
performing PE”. Participants exhibiting this attitude 
“sometimes” was 54.5% in FPs and 34.6% in SPs. 
Forty-four percent of FPs and 64.7% of SPs stated that 
“they did not prescribe drugs to their patients without 
PE”. The association between characteristics of the 
physicians and “prescribing medicines just based on 
patient complaints without PE” were also compared. 
While there was no significant correlation in FPs, a 
significant correlation was found between the answers of 
SP group and some of their characteristics. Majority of 
men (60.6%) and women (76.4%) in SP group “did not 
prescribe unless they performed a PE”. SPs having this 
attitude “sometimes” were 30.9% among juniors and 
42.6% among seniors. The percentage of SPs who stated 
that “they did not write any prescription without PE” 
were 68.1% among juniors and 57.4% in seniors. There 
was statistically significant correlation between the 
gender, age, and working duration as SP and 
“prescribing just based on complaints without PE” 
(p<0.05). Accordingly, those “writing a prescription 
based on just complaints without PE” were tended to be 
rather men, SPs above the age of 45 and junior SPs 
(Table 1).  
 
Table 1: Comparison of status of writing a prescription just upon the complaint without physical examination by 
general and professional characteristics of physicians.  
 
Level 
Have you ever written a prescription upon a complaint without performing a 
physical examination? 
FP SP 
Yes, 
always 
Yes 
sometime 
No 
Yes, 
always 
Yes 
sometime 
No 
 
G
en
d
er
 Male 
n 11 394 323 3 159 249 
% 1.5 54.1 44.4 0.7 38.7 60.6 
Female 
n 5 179 140 1 33 110 
% 1.5 55.2 43.2 0.7 22.9 76.4 
  p=0.941 p=0.002 
 
A
g
e
 
Younger  
n 4 169 127 2 59 122 
% 1.3 56.3 42.3 1.1 32.2 66.7 
Middle-aged 
n 11 329 266 2 66 154 
% 1.8 54.3 43.9 0.9 29.7 69.4 
45+ 
n 1 75 70 0 67 83 
% 0.7 51.4 47.9 0 44.7 55.3 
  p=0.691 p=0.022 
P
la
ce
 o
f 
S
p
ec
ia
li
st
 
T
ra
in
in
g
 
 University 
Hospital 
n - - - 2 99 208 
% - - - 0.6 32.0 67.3 
Training and 
Research 
Hospital 
n - - - 2 92 150 
% - - - 0.8 37.7 61.5 
  - p=0.360 
 
S
p
ec
ia
li
za
ti
o
n
  Surgical 
Sciences 
Division 
n - - - 1 57 132 
% - - - 0.5 30.0 69.5 
Medical 
Sciences 
Division 
n - - - 3 130 218 
% - - - 0.9 37.0 62.1 
   p=0.225 
W
o
rk
in
g
 
ex
p
er
ie
n
ce
 
a
ft
er
 
g
ra
d
u
a
ti
o
n
 
(y
ea
r)
 Junior 
n 10 224 176 4 117 258 
% 2.4 54.6 42.9 1.1 30.9 68.1 
Senior 
n 6 349 287 0 75 101 
% 0.9 54.4 44.7 0 42.6 57.4 
  p=0.141 p=0.012 
FP, Family Physician; SP, Specialist Physician 
More than three-fourths of physicians (77.9% of FPs, 
82.6% of SPs) mentioned that they “always” provided 
information to the patients about their illness. Only 0.5% 
of FPs and 2% of SPs declared that “they provided no 
information or only if the patients would have asked”. 
Majority of both FPs and SPs (64.9% and 68.1%, 
respectively) declared that they “always” provided 
information about the usage of prescribed drugs. 
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Physicians having this attitude “sometimes” were 32.8% 
in FP and 26.5% in SP group. Only 2.1% of the FPs and 
4.5% of the SPs stated that they provided this 
information “upon patient request”. Around half of FPs 
(50.4%) and SPs (56.1%) declared that they advised 
non-pharmacological therapy only for certain diseases. 
Moreover, %2 of FPs and 7.1% of SPs did not even offer 
non-pharmacological therapy (Table 2).  
 
Table 2: Assessment of whether physicians provide the patients with information about their disease, prescribed drugs, and non-
pharmacological therapy [the comparisons were made over the subgroups of gender, age, duration of working, and “duration of 
working as SP”. Statistically significant differences in these comparisons are indicated in the table by “a” (gender), “b” (age), “c” 
(duration of working), and “d” (duration of working as SP].  
FP, Family Physician; SP, Specialist Physician 
 
The answers of FPs and SPs regarding “providing 
information to their patients about their diseases” were 
compared by their “gender, age, and working duration”. 
No significant correlation was found among any of the 
compared strata of SPs (p>0.05). In FP group, a 
significant difference was merely detected in gender 
stratum (p<0.05), (Table 2). Accordingly, the percentage 
of females who declared to “provide information to their 
patients about their diseases” was higher (84.8%) than 
that of their male counterparts (74.9) in FP group 
(Figure). 
The answers of the FPs regarding “providing 
information to their patients about use of the drugs 
written in the prescription” were compared by their 
“gender, age, and working duration”. It was identified 
that there were statistically significant differences within 
the gender and working duration strata of the FPs 
(p<0.05), (Table 2). These comparisons showed that the 
percentage of female and junior physicians who stated to 
“give this information to their patients” were higher 
(71.3% and 68.9%, respectively) than that of male and 
senior physicians (62.1% and 59.0%, respectively) in FP 
group (Figure). The comparisons within the “gender, 
age, and working duration” strata of the SP group 
concerning “providing information to their patients 
about use of the drugs written in the prescription” 
demonstrated statistically significant differences 
(p<0.05), (Table 2). The analysis revealed significantly 
higher percentage of female, younger and junior 
physicians who declared to show this attitude always 
(76.4%, 74.7%, and 72.1%, respectively), as compared 
to that of male (65.1%), middle-aged (68.0%) and 45+ 
(60.0%), and senior SPs (61.0%), respectively (Figure). 
The responses of the FP and SP groups about 
“recommendation of non-pharmacological therapy to 
their patients” were compared by their “gender, age, and 
working duration”. While no significant difference was 
detected within subgroups of the SPs (p>0.05), gender 
stratum showed a significant difference in the FP group 
(p<0.05), (Table 2). The percentage of female physicians 
who declared to “always recommend non-
pharmacological therapy to their patients” was higher 
(31.4%) than that of male physicians (22.6%) in FP 
group (Figure).  
Considering the information provided by FPs and SPs to 
patients about their diseases, the type of information 
given by physicians most frequently were about “the 
treatment” (94.4% and 92.7%, respectively). In both FP 
and SP groups, this was followed by “the reason” 
(90.2% and 90.0%, respectively), “the name” (89.5% 
and 88.5%, respectively), “the complications” (80.6% 
and 80.5%, respectively), “the consequences” (78.2% 
and 83.2%, respectively), and “the pathophysiology” 
(35.1% and 41.3%, respectively) of the disease.
 
 
Described patient information 
 
Yes, 
always 
 
Yes, 
sometimes 
When asked 
by patients 
Only for some 
diseases 
No  
% n % n % n % n % n 
Do you give patients 
information about the 
disease? 
FP
 
a
 
77.9 820 21.6 227 0.3 3 - - 0.2 3 
SP 82.6 456 15.4 85 1.6 9 - - 0.4 2 
Do you explain 
patient how to use 
the medicine you 
prescribe? 
FP
 
a, c
 
64.9 680 32.8 344 2.1 22 - - 0.2 2 
SP a, b, d 68.1 377 26.5 147 4.5 25 - - 0.9 5 
Do you recommend 
non-pharmacological 
therapy? 
FP
 
a
 
25.3 265 22.3 233 - - 50.4 528 2.0 21 
SP 16.7 93 20.1 111 - - 56.1 310 7.1 39 
Akici et al                                                                                                                Journal of Drug Delivery & Therapeutics. 2017; 7(2):18-28                                       
ISSN: 2250-1177                                                                                   [22]                                                                        CODEN (USA): JDDTAO 
 
Figure 1: Gender distribution of information about the disease, prescribed drugs, and non-pharmacological therapy “always 
provided” by the physicians (*; p<0.005 compared to male FPs, **; p<0.05 compared to male FPs, ***; p<0.05 compared to male 
SPs). FP, Family Physician; SP, Specialist Physician 
 
When the types of information about drugs that was 
“always” provided by FPs and SPs to their patients was 
considered, most frequently given information in both 
groups was about “dosage” (59.1% and 66.1%, 
respectively); followed by “duration of treatment” 
(56.7% and 64.6%, respectively), and “administration 
way” (56.5% and 62.3%, respectively). On the other 
hand, 36.1% of FPs and 40.9% SPs declared that they 
“rarely or never” tell their patients “the name of the 
drug” (Table 3).  
 
Table 3: Distribution of drug information that physicians declared to provide their patients.  
Drug information 
FP SP 
Always Often Rarely Never  Always Often Rarely Never  
Name 
n 233 420 326 43 150 176 164 61 
% 22.8 41.1 31.9 4.2 27.2 31.9 29.8 11.1 
Administration way 
n 590 426 26 2 343 177 25 6 
% 56.5 40.8 2.5 0.2 62.3 32.1 4.5 1.1 
Dosage 
n 616 384 38 4 365 157 25 5 
% 59.1 36.9 3.6 0.4 66.1 28.5 4.5 0.9 
Duration of treatment 
n 589 406 41 4 356 173 16 6 
% 56.7 39.0 3.9 0.4 64.6 31.4 2.9 1.1 
Mechanism of action 
n 84 178 636 119 59 107 283 100 
% 8.3 17.5 62.5 11.7 10.7 19.5 51.5 18.3 
Side effects 
n 151 531 327 20 122 277 125 25 
% 14.7 51.6 31.8 1.9 22.3 50.5 22.7 4.5 
Cost 
n 37 77 537 367 29 49 209 262 
% 3.6 7.6 52.7 36.1 5.3 8.9 38.1 47.7 
Interactions 
n 117 521 358 26 74 250 187 38 
% 11.5 51.0 35.0 2.5 13.5 45.5 34.1 6.9 
Avoided activities  
n 166 461 356 37 108 242 161 39 
% 16.3 45.2 34.9 3.6 19.6 44.0 29.3 7.1 
End of treatment 
n 392 551 76 10 268 237 33 13 
% 38.1 53.5 7.4 1.0 48.6 43.0 6.0 2.4 
FP, Family Physician; SP, Specialist Physician 
 
Physicians declared that their patients requested 
prescriptions about certain drug groups “very 
frequently”, “frequently”, or “mid-frequently”. The 
drugs requested to be prescribed “very frequently” were 
“analgesic and antirheumatic drugs” (76% in FPs and 
50.5% in SPs) and “common cold drugs” (49.0% in FPs 
and 28.5% in SPs). About one-fourth of FPs declared 
that patients applied them for the demand of antibiotic 
prescription “very frequently”, “frequently”, and “mid-
frequently” (26.2%, 26.9%, and 26.1%, respectively). 
This statement about antibiotic prescriptions was 
identified in 24.2%, 29.2% and 18.9% of SP group, 
respectively (Table 4).  
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Table 4: Frequency of drug demands to be prescribed by the physicians. 
FP, Family Physician; SP, Specialist Physician; COPD, Chronic Obstructive Pulmonary Medicine 
Mean duration of interviews with patients were declared 
to be “≤5 minutes” in 30.6% of FPs and 50.3% of SPs, 
“6-10 minutes” in 52.7% of FPs and 38.0% of SPs, “11-
15 minutes” in 13.7% of FPs and 9.5% of SPs, and “>15 
minutes” in 3.0% of FPs and 2.2% of SPs. While the 
average duration for interview allocated by FPs to their 
patients was estimated to be 8 minutes and 58 seconds 
(±4 min.), this was found to be 7 minutes and 33 seconds 
(±4 min.) in SP group. FPs and SPs thought this duration 
as “insufficient” (26.3% and 35.9%, respectively) or 
“partially sufficient” (54.0% and 48.6%, respectively). 
On the other hand, substantial number of FPs and SPs 
thought this duration to be at least “>15 minutes” 
(32.8% and 28.1%, respectively).  
The relation between physicians’ daily patient volume 
and the adequate time they allocated for drug selection 
was questioned. Nearly all physicians (98.2% of FPs and 
97.2% of SPs) declared that they could have allowed 
adequate time for drug selection (i.e. identifying 
effective, safe, suitable, low-cost drugs) if the number of 
their patients had been <20 per day. The physicians who 
pointed out this number as “20-40 patients per day” 
(92.8% of FPs and 89.5% of SPs) also declared that they 
could allow adequate time for drug selection. 
Nevertheless, when it exceeded 40 patients per day, 
these numbers were shown to markedly decrease in both 
groups. When their daily volume was 41-60 patients per 
day, 50% of the FPs and 45.2% of the SPs declared that 
they were able to devote adequate time for drug 
selection. In case that it was >60 patients per day, more 
than 80% of both FPs and SPs stated that they could not 
spare adequate time for drug selection. 
Physicians’ habits of “making their patients to repeat the 
explanations” after they gave information about drug 
usage to make sure that this information was properly 
understood were analyzed. Physicians declaring to 
practice this habit “always” constituted 10.4% of FPs 
and 11.3% of SPs. Majority of physicians had the habit 
“sometimes” (73.7% of FPs and 68.8% of SPs), and 
those practicing this habit “never” were 15.9% in FP 
group and 19.9% in SP group.  
DISCUSSION  
There were 64,756 general practitioners and SPs in total, 
working in MoH in 2010 in Turkey.
18
 Considering that, 
a high level of participation of 2.5% of the FPs and SPs 
working in MoH across the country was achieved 
(63.4% and 34.6%, respectively; n=1624).  
Factors such as variety of professional experience, 
physical conditions of health institutions, and the 
number of admitted patients might have an influence on 
the knowledge, attitude, and behaviors of the physicians 
in terms of RUM.
19-21
 Considering the age and working 
duration after graduation, it can be said that in both 
groups participants “have moderate professional 
experiences”. Study data overall suggest that physicians 
in both groups do not allocate adequate time for offering 
an individualized therapy, tend to overprescribe and 
write prescriptions with large numbers of drugs, and 
experience some problems about informing their 
patients. These findings may be attributed to several 
reasons. For instance, FP and SPs declared that in 
average 52 and 48 patients per day applied them, 
respectively. 
Queried drugs 
FP SP 
Very 
frequently Frequently 
Mid-
frequently Rarely Never 
Very 
frequently Frequently 
Mid-
frequently Rarely Never 
Analgesic/ 
antirheumatic drugs 
n 790 180 53 11 5 274 151 59 23 35 
% 76.0 17.3 5.1 1.1 0.5 50.5 27.9 10.9 4.2 6.5 
Cold drugs 
n 509 341 143 34 12 151 155 89 77 58 
% 49.0 32.8 13.8 3.2 1.2 28.5 29.3 16.8 14.5 10.9 
Antibiotics 
n 275 281 273 186 31 131 158 102 113 37 
% 26.2 26.9 26.1 17.8 3.0 24.2 29.2 18.9 20.9 6.8 
Gastrointestinal 
system drugs 
n 228 413 257 97 37 100 150 111 92 77 
% 22.1 40.0 24.9 9.4 3.6 18.9 28.3 20.9 17.4 14.5 
Antihypertensives 
n 168 222 178 300 153 68 117 121 115 110 
% 16.5 21.7 17.4 29.4 15.0 12.8 22.0 22.8 21.7 20.7 
Antihyper-
lipidemics 
n 60 137 212 392 215 31 75 100 163 162 
% 5.9 13.5 20.9 38.5 21.2 5.8 14.2 18.8 30.7 30.5 
Other 
cardiovascular 
drugs 
n 88 149 180 313 281 28 69 98 169 167 
% 8.7 14.7 17.8 31.0 27.8 5.2 13.0 18.5 31.8 31.5 
Asthma / COPD 
medications 
n 43 120 277 383 189 34 55 96 170 174 
% 4.2 11.9 27.4 37.8 18.7 6.4 10.4 18.1 32.2 32.9 
Vitamin / mineral 
preparations 
n 130 194 293 334 67 60 86 103 161 120 
% 12.8 19.1 28.8 32.8 6.5 11.3 16.2 19.5 30.4 22.6 
Iron supplements 
n 37 127 363 389 96 26 49 100 204 150 
% 3.7 12.5 35.9 38.4 9.5 4.9 9.3 18.8 38.6 28.4 
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Sustainable and qualified healthcare also requires the 
daily number of patients to whom physicians provided 
care be limited. In this regard, it might be considered 
that the numbers in this study were high, carrying some 
risks in terms of RUM. In accordance with the 
principles of RUM, it is essential that physicians 
allocate sufficient time for the patient’s diagnosis and 
treatment.
2,3,22
 It is obvious that this time is in close 
association with daily number of patients applied to the 
physicians. Excessive numbers of patients may 
negatively influence the quality of the healthcare 
provided to themselves, including insufficient time 
allocated. Increased patient volume applying to 
outpatient clinics in Turkey is a long-standing problem, 
discussed for many years with ongoing efforts towards 
solutions. In fact, insufficient number of physicians is an 
important cause. Indeed, 2009 and 2010 statistics 
reported that the average number of physicians per 
100,000 people in the WHO-European-Region and 
European Union was 340 and 322, respectively, 
compared to that in Turkey, being even less than half of 
these numbers (156 physicians).
13
 
In general, depending on factors such as the content of 
the offered treatment and patient characteristics, the time 
required for treatment arrangement is expected to take a 
period of about 6-10 minutes. When the time required 
for examination and other procedures is also added, 
adequate time per patient should be >10 minutes. 
According to a study conducted in six European 
countries, it was reported that the average consultation 
time of general practitioners is 10.7 minutes, ranging 
from 7.6 to 15.9.
23
 The fact that less than 3.0% of 
physicians declared this time to be “>15 minutes” and 
that substantial number of physicians stated it to be “≤5 
minutes” (30.6% and 50.3%, respectively) were 
remarkable findings suggesting lack of time issues. 
Accordingly, the reported durations both in other 
national studies and this study could be regarded as 
lower than expected. For instance, in a study conducted 
in primary healthcare centers in Izmir, the average of 
this time was reported as 4.1 minutes.
24
 In another study 
performed in a hospital in Istanbul, 39% of the 
physicians declared this time as “≤5 minutes” and 4% of 
them “>15 minutes”.9 The lack of this time may be 
directly or indirectly associated with some other 
negative effects addressed in this study. These include, 
for example, the tendency of the physicians to prescribe 
to substantial amount of patients, even to those patients 
in whom they do not perform PE; their tendency to give 
in to the pressures from their patients in terms of drug 
prescription requests; their predisposition towards 
polypharmacy; their negligence of non-pharmacological 
recommendations; and failure to provide sufficient 
information to their patients about prescribed drugs. 
Furthermore, it was understood that the opinion of the 
physicians about “the average time required to allocate 
for a patient interview” and “the time they allocated in 
their daily routine” as mentioned above was not 
compatible. Considering the responses about their 
experiences in routine practice, it was remarkable that 
the percentages of FP (32.8%) and SPs (28.1%) stating 
this time as “>15 minutes” are more than expected. 
Though seemed as contradictory at first glance, this 
situation reveals that most of the physicians are aware of 
the insufficient time they allow for the patients during 
their daily practices. Indeed, critical findings stand out 
when the time declared to be allowed by the physicians 
for their patients is taken together with their opinions 
about whether this time is sufficient or not. For instance, 
it was observed that most of the FPs and SPs found this 
time either “insufficient” (26.3% and 35.9%, 
respectively) or “partially sufficient” (54% and 48.6%, 
respectively). These findings were detected to be 
comparable with the results of the study conducted in 
Istanbul, where 84% of the physicians were reported to 
declare this time as insufficient.
9
 All of these findings 
actually suggest that physicians experience time issues 
during patient interviews and that they were aware of 
this. This awareness can be interpreted as a sign of 
physicians’ dissatisfactions with current situation in 
terms of RUM, hence being open to change. These 
approaches of the physicians should be properly 
considered whilst planning the dissemination activities 
regarding RUM.  
Apart from leading to allocation of insufficient time to 
the patients, an increase of the number of patients per 
day may also cause other quality problems in healthcare 
services. For instance, the chance “to provide adequate 
time for drug selection” that is essential for a successful 
therapeutic approach may not be efficiently achieved in 
the settings with a heavy patient load. Within the 
framework of the RUM principles, physicians should 
carefully use “efficacy, safety, suitability, and cost” 
criteria while choosing drugs in a rational manner.
1
 In 
our study, insufficient time allowed for drug choosing 
was found to be associated with the daily volume of 
patients applied to the physicians. Accordingly, it 
appears that almost all physicians could allow enough 
time for drug choosing if the number of patients per day 
is <20, whereas this duration is negatively affected by 
an increase in daily number of patients. In this study, the 
approaches of the FP and SPs about RUM differ from 
each other in some respects. For instance, it was 
remarkable that the SPs examined more patients and 
wrote less prescriptions than the FPs. The percentage of 
patients examined by FPs was less than that by SPs 
(those declaring to “examine more than three-fourth of 
their patients” are 40.1% and 84.9%, respectively). This 
finding is also supported by another study conducted in 
2010 in the same places as this study, where patients 
declared that 72.8% of them in FHC and 89.9% of them 
in SH were examined by the physicians.
25
 Identification 
of these findings pursuant to patient and physician 
statements might be associated with various 
characteristics of patients applying primary care centers 
and hospitals. Indeed, in a patient survey-based study, 
the percentage of those not examined upon applying for 
“control visit and demands for prescription or resting 
report” in FHCs was reported to be higher than that seen 
in SHs.
25
 
Leading to such problems as unnecessary and 
inappropriate drug consumption, drug-drug interactions, 
facilitation of development of resistance and tolerance to 
various drugs, and increased treatment costs; 
polypharmacy is a major type of IUM that should be 
avoided. Indeed, NDPP is one of the INRUD 
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(International Network for the Rational Use of Drugs) 
criteria of the WHO. An elevated value is deemed to be 
against RUM, which is demanded to be decreased by 
reducing NDPP.
1,17
 It was detected that FPs prescribed 
more drugs per prescription compared to SPs (3.27 and 
3.07 drug items in average, respectively). When the 
NDPP was grouped by their numbers, it was 
encountered that no one among FPs and only a few 
physicians in SPs (0.9%) has the habit of writing only 
one drug item per prescription. In a study conducted in 
Andorra, the percentage of prescriptions with one drug 
item was reported as 31.8%.
19
 A US study in 2009 
reported “at least one drug item per prescription” for 
68.1% of the population whose medical records were 
analyzed, “≥2 drug items per prescription” for 51.6% of 
those and “≥5 drug items per prescription” for 21.2% of 
the population were written.
26
 In a study conducted in 
similar health centers and provinces in 2009, the NDPPs 
were reported to be 2.96 and 2.75 in FHCs and SHs, 
respectively.
27
 Other studies conducted in Turkey 
between 1998-2005 reported these values as 2.9, 3.3, 
and 3.5.
24,28,29
 Based on both our study as well as most 
of the other studies in published literature, it may be 
suggested that FPs partly tend to write more drugs to 
their prescriptions than that of SPs. It may be advocated 
that generally the physicians in Turkey, more 
prominently the FPs, tend to practice polypharmacy, 
compared with the results of the published studies 
conducted in various Asian countries, reporting NDPPs 
between 2.08-2.91.
12,30-33
 
Prescription without PE is the leading unfavorable 
practice performed by the physicians in terms of RUM. 
Writing a prescription to the patient without performing 
the required PE, and hence skipping confirmation of the 
diagnosis is an unacceptable attitude regarding RUM. In 
our study, only 44.0% of the FPs and 64.7% of the SPs 
declared that “they do not write a prescription for their 
patients without PE” while others declared that they 
always or sometimes exhibited this behavior, reflecting 
IUM habits of the physicians in overall. This could be 
considered as one of the significant findings of the 
study, addressing the need for RUM-based interventions 
to correct. As in this study, the other studies conducted 
in Turkey also show that the tendency “to prescribe 
upon complaints of the patients without PE” is usually 
high. In a study in Istanbul, patients reported that this 
habit was practiced as “always” and “sometimes” by 
14% and 36.6% of the physicians.
22
 In a study 
conducted in the same city in primary care, it was 
reported that 58.3% of the physicians “prescribed 
without performing PE”.29 In our study, it has been 
observed that the habits of the physicians about this 
issue showed a difference between FPs and SPs. In this 
regard, it is remarkable that FPs show within-group 
similarities while a more heterogeneous approach is 
shown among the SPs. Accordingly, it is understood that 
the tendency to exhibit this habit is more common 
among male SPs, those who are >45 years, and junior 
SPs.  
According to the RUM principles, providing 
information to patients about their diseases is one of the 
most important responsibilities of the physician.
1,2,4,8
 In 
our study, 77.9% of the FPs and 82.6% of the SPs 
declared that they “always” inform the patients about 
their diseases, which can be considered as positive. 
However, this attitude is expected to be 100% 
independent from any conditions. Two studies 
conducted in Istanbul reported this attitude to be shown 
by 62.2% and 74.7% of the physicians.
34,7
 Though it has 
been partially improved compared to past, the 
expectations about this issue has not been completely 
met yet.  
One of the impressive findings of the study is that the 
habit of “providing information to the patients about 
their diseases” varies on gender. Although no significant 
difference was observed in SPs, females were found to 
be more successful than males among FPs in this regard. 
Consistent with this finding, female physicians in the 
primary care were demonstrated to allocate more times 
for their patients and provide more comprehensive 
healthcare than their male counterparts, as reported by 
two different studies conducted in the United States 
(USA) and the Netherlands.
21,35
  
Both FP and SP groups revealed that physicians mostly 
(94.4% and 92.7%, respectively) inform their patients 
“about their treatments”, which can be regarded as 
favorable at first glance. However, when the details of 
the treatment were interrogated, it was observed that 
these attitudes of the physicians were below the 
expectations, which vary by the groups and some of the 
demographic characteristics within these groups. Our 
study showed that FPs and SPs highly declared that they 
“always” or “sometimes” informed their patients about 
the usage of the drugs prescribed. It was identified that 
these responses had similarities with a previous study.
34
 
As reported by a patient survey across Turkey in 2010, 
patients declared that the physicians in FHCs and SHs 
informed vast majority of their patients about drugs per 
se (89.1% and 87.8%, respectively) while the remaining 
were only informed if they would have asked (10.9% in 
FHCs and 12.2% in SHs).
25
 In other respects, it is 
noteworthy that the habit of “giving patients information 
about drugs” differed by some characteristics of the 
physicians in our study. In both FPs and SPs, this habit 
was observed to be practiced successfully by females 
and youngers, compared to males and older ones, 
respectively. This pointed out the differences required to 
be considered in RUM improvement activities 
applicable for physicians. 
Regardless of whether offered treatments consist of 
drugs or not, non-pharmacological therapy should be 
recommended almost in every disease, including many 
life style modifications, practices, etc. It is essential that 
physicians make a clear explanation concerning these 
instructions to their patients.
1,2,4,8
 Our study pointed out 
that the number of the physicians providing this 
information was less than expected (50.4% of the FPs 
and 56.1% of the SPs). Earlier studies in Turkey 
reported this information to be provided between 18.8-
62.6%.
7,9,22,34
 When our results were compared with 
those published in the literature, it is figured out that 
although partially improved, incompetence of the 
physicians substantially continues. Furthermore, it is 
remarkable that males and SPs were much more 
inadequate compared to females and FPs, respectively.  
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Information such as dosage, administration way, 
duration of treatment, etc. should “always” be 
thoroughly explained to the patients by their physicians 
managing the treatment. It is non-excusable that this 
information could be imperfectly given to the patients 
by some justifications arguing that they can be obtained 
“from the pharmacist or by reading the prescription”. 
Such negative approaches are among the major 
problems of the IUM, causing many potential health 
problems and economic losses.
2,16,29,36
 When the 
frequency of the kind of information about drugs 
“always” provided to the patients by FPs and SPs in this 
study was analyzed, it was observed that these 
expectations remain well behind in both groups. Among 
these types of treatment-related information, FP and SPs 
mostly preferred to provide information about “dosage”, 
“duration of treatment”, and “administration way”. A 
patient interview study identified similar frequencies, 
where patients were reported to be most frequently 
informed about “the dosage” and “duration of 
treatment”.25 Consistent with those in the literature, this 
finding suggests that physicians’ statements overlap that 
of patients, implying these attitudes of the physicians to 
reflect on their behaviors. A study conducted in the 
USA reported that at the time of discharge, 80% of the 
patients received instructions about their medications 
and 76% of them got information about their diseases.
37
 
The effectiveness or ineffectiveness of prescribed drugs 
are directly related to adopting good practices. A 
physician is expected to confine this information not to 
some subheadings, yet to extend it covering all the 
aspects of the drug: the name, duration of use, 
therapeutic effects, possible adverse effects, etc. 
Incompetency of an informative approach in this manner 
might also be associated with other before-mentioned, 
unfavorable attitudes of the physicians. Moreover, it is 
closely associated with reasons such as excess workload 
of the physicians due to extreme numbers of patients, 
insufficient time for patient care, demands for 
prescriptions, etc. On the other hand, delivery of this 
performance at an expected level requires the physician 
to have sufficient knowledge of pharmacology, where 
diverse problems worldwide were shown to exist. 
Problem-based rational pharmacotherapy trainings 
which has become gradually widespread and 
recommended by WHO contribute to the solution of the 
problem.
1,2,5,6,38
 In this respect, Turkey has made 
progress in last decade.
8,29,39
 The results of our study 
suggests the necessity of these trainings provided to 
physicians and physician candidates to be further 
disseminated.  
Patients may demand for prescriptions of the drugs that 
they are using or they are going to use due to various 
reasons. This may lead to serious IUM problems in case 
the physician loses command over it. In this study, 
physicians in FP and SP groups declared that patients 
“most frequently or frequently” applied them to demand 
for prescriptions of “analgesics/antirheumatics”, “cold 
drugs”, and “antibiotics”. Analgesics and cold drugs are 
among the frequently preferred drugs by the patients for 
“self-medication”. In fact, such irrational use of these 
drugs is common. A German study of over-the-counter 
(OTC) self-medication usage in children and 
adolescents between 2003-2006 reported that 32.1% of 
the detected drugs were associated with respiratory 
system and that there were major problems concerning 
inappropriate use.
40
 In a study conducted in Australia 
between 2006-2007, it was reported that parents often 
made their children use OTC medications, and that over 
40% of the parents made them use those cough and cold 
drugs with efficacy issues and safety risks.
41
 Overuse of 
the antibiotics in Turkey has reached very critical levels, 
far above the world average.
15
 In order to solve this 
problem, the health authority addressed this issue as the 
top priority in RUM spreading program.
42
 The fact that 
antibiotics were also among the drugs often tried to be 
demanded by the patients for prescriptions in our study, 
is an important detection disclosing the irrational 
antibiotic usage problem in this manner. This reveals the 
need for public awareness activities in terms of RUM, 
particularly for specific leading drug groups.  
During planning of a treatment with respect to the RUM 
principles, physicians should make sure that provided 
information is properly understood by the patients. 
Therefore, after explaining the use of the drugs to their 
patients, physicians should have their patients to repeat 
these instructions so as to ensure that whole information 
is properly and sufficiently understood and fill any 
possible gaps in their mind.
2,9,29
 In a modelling study 
testing the comprehensibleness of the given medical 
information to the patients, it was reported that “the 
model positioning the patients at the center and 
facilitating a collaboration by making them to repeat 
what they told” would be thought to be better 
understood by the patients, and consequently preferred 
more than its alternative options.
43
 Another study in the 
USA reported that the opportunity to confirm that the 
provided information was understood was offered to 
only 22% of the patients.
37
 As in most of the other 
studies in the literature, it is also understood in this 
study that most of the FPs and SPs do not adopt “this 
repeating process which make great contributions to the 
comprehensibleness” much. In three different studies, 
few physicians were reported to practice this behavior 
(8.8 to 11.6%).
7,9,34
 After writing a prescription for the 
patients, it is a rational approach to listen to how much 
they have understood, and to repeat missed or 
misunderstood parts of provided information again. This 
repeating behavior, which is critical for both the 
implementation of RUM and identification of the 
position of the patient about performing what is 
instructed, was found to be inadequate as other 
previously published studies, remarking continuance of 
these shortcomings and the need for their obviation.  
Our study has some limitations. Collection of data only 
during May, excluding other time periods, has ignored 
probable diversities of answers due to seasonal 
differences, which may affect some of the answers in the 
survey. For instance, the experiences of the physicians 
regarding frequency of patient demands for prescriptions 
of cold drugs and antibiotics (as they might be easily 
reminded) may be influenced from seasonal factors. 
This possibility might be listed among the limitations of 
the study. Despite having a weak possibility, some other 
unquestioned characteristics of the FP and SPs might 
influence their responses. Beside, specific questions 
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related to their expertise in terms of RUM was not asked 
in the survey applied to the SPs. These were not 
included to the study to exempt it from too much 
detailed information and to avoid the risk of reduction of 
physicians’ responsiveness by asking excessive numbers 
of questions, which may be regarded as another 
limitation of the study.  
CONCLUSION 
In conclusion, with a high participation considered to 
represent Turkey in general, our study analyzed 
approaches of the physicians towards planning of the 
treatment and introduced the perspectives of the 
physicians about these issues in terms of RUM in detail. 
When the overall data of the study are considered, it is 
noteworthy that physicians in both groups did not 
allocate adequate time for planning the treatment, tended 
to overprescribe and write too many drugs on 
prescriptions, and experienced several problems in 
providing their patients with sufficient information. It 
could be observed that the approaches of the physicians 
about treatment process might be influenced by some of 
their demographic characteristics and by being either a 
FP or a SP. In particular, although more marked among 
FPs, female physicians are more likely to inform their 
patients about their disease, the drugs they prescribed, 
and non-pharmacological treatment. It would be useful 
to prioritize these findings during RUM dissemination 
activities that will be implemented both in Turkey and in 
other countries.  
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